Abstract
Background and Aims: Polycystic Ovary Syndrome (PCOS) is associated with increased cardiometabolic risk factors and cardiovascular disease (CVD). Currently, there is a need to assess early CVD in high-risk women with and without PCOS to effectively prevent morbidity from CVD. Objective: The aim of this study was to provide evidence-based research to aid assessment guidelines for early detection of dyslipidaemia, cardiac dysfunction and subclinical atherosclerosis in women with and without PCOS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
